Clinical Trial Update: Effect of Rifampin on the Pharmacokinetics of BAY73-4506 [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the effect of rifampin on the pharmacokinetics of BAY73-4506 in patients with Neoplasms. The study informs potential drug-drug interact…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• BAY73-4506 (BAY-73-4506)
• RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: Bayer | Conditions: Neoplasms | Phase 1 | Status: COMPLETED